Vesalius Biocapital is a European life sciences venture capital investor. The active fund Vesalius Biocapital III had a first closing in May 2017 – currently, over € 75 million are managed.
Investment Type: Venture Capital
Portfolio 10
| Date | Name | Website | Total Raised | Location |
| - | Memo Thera... | memo-thera... | $84.15M | Switzerlan... |
| - | Tonic App | tonicapp.c... | $3.89M | Portugal, ... |
| - | Caresyntax | caresyntax... | $273.8M | United Sta... |
| - | Scenic Bio... | scenicbiot... | $38.39M | Netherland... |
| - | Rejuvenate... | rejuvenate... | $18.14M | Belgium, L... |
| - | Topas Ther... | topas-ther... | $63.15M | Germany, H... |
| - | Mecuris | mecuris.co... | $8.12M | Germany, B... |
| - | Forendo Ph... | forendo.co... | $13.93M | - |
| - | DEARhealth | dearhealth... | $6.8M | United Sta... |
| - | Catalym | catalym.co... | $111.12M | Germany, B... |
Mentions in press and media 2
| Date | Title | Description | Source |
| 17.02.2020 | Internacional: OncoDNA cierra una ronda Serie B de €19M, acu... | 17/02/2020 Nota de prensa INTERNACIONAL: ONCODNA CIERRA UNA RONDA SERIE B DE €19 MILLONES, ACUDEN ... | webcapital... |
| 25.06.2019 | Vesalius Biocapital III Closes €120M Life Sciences Focused F... | Vesalius Biocapital III, the Strassen, Luxembourg-based specialist life sciences venture capital inv... | finsmes.co... |